VOYA INVESTMENT MANAGEMENT LLC - CLOVIS ONCOLOGY INC ownership

CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 164 filers reported holding CLOVIS ONCOLOGY INC in Q4 2020. The put-call ratio across all filers is 1.33 and the average weighting 0.0%.

Quarter-by-quarter ownership
VOYA INVESTMENT MANAGEMENT LLC ownership history of CLOVIS ONCOLOGY INC
ValueSharesWeighting
Q1 2022$85,000
-25.4%
41,9320.0%0.00%
Q4 2021$114,000
-41.5%
41,932
-4.0%
0.00%
Q3 2021$195,000
-15.2%
43,691
+10.3%
0.00%
Q2 2021$230,000
-8.7%
39,594
+10.3%
0.00%
-100.0%
Q1 2021$252,000
+51.8%
35,905
+3.9%
0.00%
Q4 2020$166,000
+2.5%
34,573
+24.4%
0.00%
Q3 2020$162,000
-4.1%
27,792
+10.7%
0.00%
Q2 2020$169,000
+7.6%
25,103
+1.6%
0.00%
Q1 2020$157,000
-39.1%
24,7050.0%0.00%
-100.0%
Q4 2019$258,000
+226.6%
24,705
+23.2%
0.00%
Q3 2019$79,000
-98.6%
20,051
-94.7%
0.00%
-100.0%
Q2 2019$5,617,000
-25.4%
377,777
+24.5%
0.01%
-29.4%
Q1 2019$7,533,000
-43.1%
303,475
-58.8%
0.02%
-48.5%
Q4 2018$13,240,000
-41.1%
737,188
-3.7%
0.03%
-28.3%
Q3 2018$22,486,000
-22.9%
765,620
+19.3%
0.05%
-25.8%
Q2 2018$29,172,000
+2.8%
641,570
+19.4%
0.06%
+1.6%
Q1 2018$28,377,000
-3.8%
537,456
+23.8%
0.06%0.0%
Q4 2017$29,512,000
-12.9%
433,999
+5.6%
0.06%
-16.4%
Q3 2017$33,867,000
+85.5%
411,010
+110.8%
0.07%
+78.0%
Q2 2017$18,255,000
+55.0%
194,969
+5.4%
0.04%
+51.9%
Q1 2017$11,776,000
+2025.6%
184,961
+1383.4%
0.03%
+2600.0%
Q4 2016$554,000
+6.1%
12,469
-13.9%
0.00%0.0%
Q3 2016$522,000
+162.3%
14,4890.0%0.00%
Q2 2016$199,000
-13.9%
14,489
+20.7%
0.00%
-100.0%
Q1 2016$231,000
-45.0%
12,0060.0%0.00%0.0%
Q4 2015$420,000
-96.8%
12,006
-91.5%
0.00%
-97.0%
Q3 2015$13,007,000
+36.3%
141,445
+30.3%
0.03%
+50.0%
Q2 2015$9,541,000
-25.4%
108,570
-37.0%
0.02%
-21.4%
Q1 2015$12,785,000
-4.3%
172,248
-27.8%
0.03%
-6.7%
Q4 2014$13,354,000
+14.6%
238,472
-7.2%
0.03%
+15.4%
Q3 2014$11,653,000
+36.1%
256,897
+24.2%
0.03%
+30.0%
Q2 2014$8,565,000
-5.2%
206,835
+58.6%
0.02%
-4.8%
Q1 2014$9,034,000
+1395.7%
130,415
+1201.2%
0.02%
+2000.0%
Q4 2013$604,000
+11.2%
10,023
+12.2%
0.00%0.0%
Q3 2013$543,000
-9.3%
8,9360.0%0.00%
-50.0%
Q2 2013$599,0008,9360.00%
Other shareholders
CLOVIS ONCOLOGY INC shareholders Q4 2020
NameSharesValueWeighting ↓
Coppell Advisory Solutions LLC 229$11,0080.00%
View complete list of CLOVIS ONCOLOGY INC shareholders